| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| May 8, 2026 | ±4.6% | +2.5% | over-priced |
| November 6, 2025 | ±4.0% | -1.3% | over-priced |
| August 8, 2025 | ±3.7% | +0.8% | over-priced |
| May 12, 2025 | ±3.5% | +4.6% | under-priced |
| November 8, 2024 | ±4.5% | +1.3% | over-priced |
| May 9, 2024 | ±3.8% | +2.7% | over-priced |
| November 6, 2023 | ±3.6% | -2.8% | over-priced |
| August 3, 2023 | ±2.7% | -0.7% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2026 | — | $1.3B | $223M |
| Q4 FY2025 | — | $1.6B | $72M |
| Q3 FY2025 | — | $1.2B | $473M |
| Q2 FY2025 | — | $1.0B | $222M |
Ares Management Corporation Class A Common Stock (ARES) reports in 100 days, with the next report estimated for September 21, 2026. Across the last 8 reports, options priced an average ±3.8% earnings move while the stock actually moved 2.1% on average — the market has systematically over-priced ARES's earnings risk. Fundamentals into the print: EPS up 0.0% year-over-year, revenue up 29.3%. QuantLogix's live 5-factor engine currently reads ARES as a buy at 51/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →